Role of the staphylococcal nuclease and tudor domain containing 1 in oncogenesis (Review)

Jariwala,Nidhi; Rajasekaran,Devaraja; Srivastava,Jyoti; Gredler,Rachel; Akiel,Maaged A.; Robertson,Chadia L.; Emdad,Luni; Fisher,Paul B.; Sarkar,Devanand

doi:10.3892/ijo.2014.2766

Role of the staphylococcal nuclease and tudor domain containing 1 in oncogenesis (Review)

Authors:
- Nidhi Jariwala
- Devaraja Rajasekaran
- Jyoti Srivastava
- Rachel Gredler
- Maaged A. Akiel
- Chadia L. Robertson
- Luni Emdad
- Paul B. Fisher
- Devanand Sarkar
View Affiliations

Affiliations: Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA, USA
Published online on: November 18, 2014 https://doi.org/10.3892/ijo.2014.2766
Pages: 465-473

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The staphylococcal nuclease and tudor domain containing 1 (SND1) is a multifunctional protein overexpressed in breast, prostate, colorectal and hepatocellular carcinomas and malignant glioma. Molecular studies have revealed the multifaceted activities of SND1 involved in regulating gene expression at transcriptional as well as post-transcriptional levels. Early studies identified SND1 as a transcriptional co-activator. SND1 is also a component of RNA-induced silencing complex (RISC) thus mediating RNAi function, a regulator of mRNA splicing, editing and stability, and plays a role in maintenance of cell viability. Such diverse actions allow the SND1 to modulate a complex array of molecular networks, thereby promoting carcinogenesis. Here, we describe the crucial role of SND1 in cancer development and progression, and highlight SND1 as a potential target for therapeutic intervention.

View Figures

View References

1	Hanahan D and Weinberg RA: Hallmarks of cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
2	Almendro V, Marusyk A and Polyak K: Cellular heterogeneity and molecular evolution in cancer. Annu Rev Pathol. 8:277–302. 2013. View Article : Google Scholar
3	Callebaut I and Mornon JP: The human EBNA-2 coactivator p100: multidomain organization and relationship to the staphylococcal nuclease fold and to the tudor protein involved in Drosophila melanogaster development. Biochem J. 321:125–132. 1997.PubMed/NCBI
4	Yang J, Aittomaki S, Pesu M, et al: Identification of p100 as a coactivator for STAT6 that bridges STAT6 with RNA polymerase II. EMBO J. 21:4950–4958. 2002. View Article : Google Scholar : PubMed/NCBI
5	Gao X, Zhao X, Zhu Y, et al: Tudor staphylococcal nuclease (Tudor-SN) participates in small ribonucleoprotein (snRNP) assembly via interacting with symmetrically dimethylated Sm proteins. J Biol Chem. 287:18130–18141. 2012. View Article : Google Scholar : PubMed/NCBI
6	Caudy AA, Ketting RF, Hammond SM, et al: A micrococcal nuclease homologue in RNAi effector complexes. Nature. 425:411–414. 2003. View Article : Google Scholar : PubMed/NCBI
7	Paukku K, Kalkkinen N, Silvennoinen O, Kontula KK and Lehtonen JY: p100 increases AT1R expression through interaction with AT1R 3′-UTR. Nucleic Acids Res. 36:4474–4487. 2008. View Article : Google Scholar : PubMed/NCBI
8	Paukku K, Yang J and Silvennoinen O: Tudor and nuclease-like domains containing protein p100 function as coactivators for signal transducer and activator of transcription 5. Mol Endocrinol. 17:1805–1814. 2003. View Article : Google Scholar : PubMed/NCBI
9	Leverson JD, Koskinen PJ, Orrico FC, et al: Pim-1 kinase and p100 cooperate to enhance c-Myb activity. Mol Cell. 2:417–425. 1998. View Article : Google Scholar : PubMed/NCBI
10	Garcia-Lopez J, de Hourcade JD and Del Mazo J: Reprogramming of microRNAs by adenosine-to-inosine editing and the selective elimination of edited microRNA precursors in mouse oocytes and preimplantation embryos. Nucleic Acids Res. 41:5483–5493. 2013. View Article : Google Scholar : PubMed/NCBI
11	Li CL, Yang WZ, Chen YP and Yuan HS: Structural and functional insights into human Tudor-SN, a key component linking RNA interference and editing. Nucleic Acids Res. 36:3579–3589. 2008. View Article : Google Scholar : PubMed/NCBI
12	Yoo BK, Santhekadur PK, Gredler R, et al: Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma. Hepatology. 53:1538–1548. 2011. View Article : Google Scholar : PubMed/NCBI
13	Ho J, Kong JW, Choong LY, et al: Novel breast cancer metastasis-associated proteins. J Proteome Res. 8:583–594. 2009. View Article : Google Scholar
14	Blanco MA, Aleckovic M, Hua Y, et al: Identification of staphylococcal nuclease domain-containing 1 (SND1) as a Metadherin-interacting protein with metastasis-promoting functions. J Biol Chem. 286:19982–19992. 2011. View Article : Google Scholar : PubMed/NCBI
15	Wan L, Lu X, Yuan S, et al: MTDH- SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors. Cancer Cell. 26:92–105. 2014. View Article : Google Scholar : PubMed/NCBI
16	Santhekadur PK, Akiel M, Emdad L, et al: Staphylococcal nuclease domain containing-1 (SND1) promotes migration and invasion via angiotensin II type 1 receptor (AT1R) and TGFbeta signaling. FEBS Open Bio. 4:353–361. 2014. View Article : Google Scholar
17	Santhekadur PK, Das SK, Gredler R, et al: Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor kappaB and miR-221. J Biol Chem. 287:13952–13958. 2012. View Article : Google Scholar : PubMed/NCBI
18	Kuruma H, Kamata Y, Takahashi H, et al: Staphylococcal nuclease domain-containing protein 1 as a potential tissue marker for prostate cancer. Am J Pathol. 174:2044–2050. 2009. View Article : Google Scholar : PubMed/NCBI
19	Tsuchiya N, Ochiai M, Nakashima K, Ubagai T, Sugimura T and Nakagama H: SND1, a component of RNA-induced silencing complex, is up-regulated in human colon cancers and implicated in early stage colon carcinogenesis. Cancer Res. 67:9568–9576. 2007. View Article : Google Scholar : PubMed/NCBI
20	Emdad L, Janjic A, Al-Zubi M, et al: Suppression of miR-184 in malignant gliomas upregulates SND1 and promotes tumor aggressiveness. Neuro Oncol. Sep 12–2014.(Epub ahead of print). pii: nou220. View Article : Google Scholar : PubMed/NCBI
21	Lienard P, Riviere M, Van Vooren P, Szpirer C and Szpirer J: Assignment of SND1, the gene encoding coactivator p100, to human chromosome 7q31.3 and rat chromosome 4q23 by in situ hybridization. Cytogenet Cell Genet. 90:253–254. 2000. View Article : Google Scholar : PubMed/NCBI
22	Voeghtly LM, Mamula K, Campbell JL, Shriver CD and Ellsworth RE: Molecular alterations associated with breast cancer mortality. PLoS One. 7:e468142012. View Article : Google Scholar : PubMed/NCBI
23	Jenkins RB, Qian J, Lee HK, et al: A molecular cytogenetic analysis of 7q31 in prostate cancer. Cancer Res. 58:759–766. 1998.PubMed/NCBI
24	Glukhova L, Lavialle C, Fauvet D, et al: Mapping of the 7q31 subregion common to the small chromosome 7 derivatives from two sporadic papillary renal cell carcinomas: increased copy number and overexpression of the MET proto-oncogene. Oncogene. 19:754–761. 2000. View Article : Google Scholar : PubMed/NCBI
25	Theobald DL, Mitton-Fry RM and Wuttke DS: Nucleic acid recognition by OB-fold proteins. Annu Rev Biophys Biomol Struct. 32:115–133. 2003. View Article : Google Scholar : PubMed/NCBI
26	Ying M and Chen D: Tudor domain-containing proteins of Drosophila melanogaster. Dev Growth Differ. 54:32–43. 2012. View Article : Google Scholar : PubMed/NCBI
27	Armengol S, Arretxe E, Rodriguez L, Ochoa B, Chico Y and Martinez MJ: NF-kappaB, Sp1 and NF-Y as transcriptional regulators of human SND1 gene. Biochimie. 95:735–742. 2013. View Article : Google Scholar
28	Rodriguez L, Bartolome N, Ochoa B and Martinez MJ: Isolation and characterization of the rat SND p102 gene promoter: putative role for nuclear factor-Y in regulation of transcription. Ann NY Acad Sci. 1091:282–295. 2006. View Article : Google Scholar
29	Rodriguez L, Ochoa B and Martinez MJ: NF-Y and Sp1 are involved in transcriptional regulation of rat SND p102 gene. Biochem Biophys Res Commun. 356:226–232. 2007. View Article : Google Scholar : PubMed/NCBI
30	Fashe T, Saarikettu J, Isomaki P, Yang J and Silvennoinen O: Expression analysis of Tudor-SN protein in mouse tissues. Tissue Cell. 45:21–31. 2013. View Article : Google Scholar
31	Keenan TW, Winter S, Rackwitz HR and Heid HW: Nuclear coactivator protein p100 is present in endoplasmic reticulum and lipid droplets of milk secreting cells. Biochim Biophys Acta. 1523:84–90. 2000. View Article : Google Scholar : PubMed/NCBI
32	Tong X, Drapkin R, Yalamanchili R, Mosialos G and Kieff E: The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE. Mol Cell Biol. 15:4735–4744. 1995.PubMed/NCBI
33	Valineva T, Yang J, Palovuori R and Silvennoinen O: The transcriptional co-activator protein p100 recruits histone acetyl-transferase activity to STAT6 and mediates interaction between the CREB-binding protein and STAT6. J Biol Chem. 280:14989–14996. 2005. View Article : Google Scholar
34	Bromberg J: Stat proteins and oncogenesis. J Clin Invest. 109:1139–1142. 2002. View Article : Google Scholar : PubMed/NCBI
35	Liu X, Dong L, Zhang X, et al: Identification of p100 target promoters by chromatin immunoprecipitation-guided ligation and selection (ChIP-GLAS). Cell Mol Immunol. 8:88–91. 2011. View Article : Google Scholar
36	Sarkar D and Fisher PB: AEG-1/MTDH/LYRIC: clinical significance. Adv Cancer Res. 120:39–74. 2013. View Article : Google Scholar : PubMed/NCBI
37	Yoo BK, Emdad L, Lee SG, et al: Astrocyte elevated gene-1 (AEG-1): A multifunctional regulator of normal and abnormal physiology. Pharmacol Ther. 130:1–8. 2011. View Article : Google Scholar : PubMed/NCBI
38	Milochau A, Lagree V, Benassy MN, et al: Synaptotagmin 11 interacts with components of the RNA-induced silencing complex RISC in clonal pancreatic beta-cells. FEBS Lett. 588:2217–2222. 2014. View Article : Google Scholar : PubMed/NCBI
39	Heinrich EM, Wagner J, Kruger M, et al: Regulation of miR-17-92a cluster processing by the microRNA binding protein SND1. FEBS Lett. 587:2405–2411. 2013. View Article : Google Scholar : PubMed/NCBI
40	Gao X, Shi X, Fu X, et al: Human Tudor staphylococcal nuclease (Tudor-SN) protein modulates the kinetics of AGTR1–3′UTR granule formation. FEBS Lett. 588:2154–2161. 2014. View Article : Google Scholar : PubMed/NCBI
41	Lei Y, Huang Y, Zhang H, Yu L, Zhang M and Dayton A: Functional interaction between cellular p100 and the dengue virus 3′ UTR. J Gen Virol. 92:796–806. 2011. View Article : Google Scholar
42	Wahl MC, Will CL and Luhrmann R: The spliceosome: design principles of a dynamic RNP machine. Cell. 136:701–718. 2009. View Article : Google Scholar : PubMed/NCBI
43	David CJ and Manley JL: Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev. 24:2343–2364. 2010. View Article : Google Scholar : PubMed/NCBI
44	Yang J, Valineva T, Hong J, et al: Transcriptional co-activator protein p100 interacts with snRNP proteins and facilitates the assembly of the spliceosome. Nucleic Acids Res. 35:4485–4494. 2007. View Article : Google Scholar : PubMed/NCBI
45	Cappellari M, Bielli P, Paronetto MP, et al: The transcriptional co-activator SND1 is a novel regulator of alternative splicing in prostate cancer cells. Oncogene. 33:3794–3802. 2014. View Article : Google Scholar
46	Nishikura K: Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem. 79:321–349. 2010. View Article : Google Scholar : PubMed/NCBI
47	Gao X, Ge L, Shao J, et al: Tudor-SN interacts with and co-localizes with G3BP in stress granules under stress conditions. FEBS Lett. 584:3525–3532. 2010. View Article : Google Scholar : PubMed/NCBI
48	Weissbach R and Scadden AD: Tudor-SN and ADAR1 are components of cytoplasmic stress granules. RNA. 18:462–471. 2012. View Article : Google Scholar : PubMed/NCBI
49	Sundstrom JF, Vaculova A, Smertenko AP, et al: Tudor staphylococcal nuclease is an evolutionarily conserved component of the programmed cell death degradome. Nat Cell Biol. 11:1347–1354. 2009. View Article : Google Scholar : PubMed/NCBI
50	El-Serag HB: Hepatocellular carcinoma. N Engl J Med. 365:1118–1127. 2011. View Article : Google Scholar : PubMed/NCBI
51	Villanueva A, Hernandez-Gea V and Llovet JM: Medical therapies for hepatocellular carcinoma: a critical view of the evidence. Nat Rev Gastroenterol Hepatol. 10:34–42. 2013. View Article : Google Scholar
52	Llovet JM, Ricci S, Mazzaferro V, et al: Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 359:378–390. 2008. View Article : Google Scholar : PubMed/NCBI
53	Yin J, Ding J, Huang L, et al: SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression. Anat Rec. 296:1568–1575. 2013. View Article : Google Scholar
54	Nguyen DX, Bos PD and Massague J: Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 9:274–284. 2009. View Article : Google Scholar : PubMed/NCBI
55	Brown DM and Ruoslahti E: Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell. 5:365–374. 2004. View Article : Google Scholar : PubMed/NCBI
56	Hu G, Chong RA, Yang Q, et al: MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell. 15:9–20. 2009. View Article : Google Scholar :
57	Yoo BK, Emdad L, Su ZZ, et al: Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest. 119:465–477. 2009. View Article : Google Scholar : PubMed/NCBI
58	Yoo BK, Chen D, Su ZZ, et al: Molecular mechanism of chemoresistance by astrocyte elevated gene-1. Cancer Res. 70:3249–3258. 2010. View Article : Google Scholar : PubMed/NCBI
59	Emdad L, Lee SG, Su ZZ, et al: Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis. Proc Natl Acad Sci USA. 106:21300–21305. 2009. View Article : Google Scholar : PubMed/NCBI
60	Liu W, Beck BH, Vaidya KS, et al: Metastasis suppressor KISS1 seems to reverse the Warburg effect by enhancing mitochondrial biogenesis. Cancer Res. 74:954–963. 2014. View Article : Google Scholar
61	Quintana AM, Liu F, O’Rourke JP and Ness SA: Identification and regulation of c-Myb target genes in MCF-7 cells. BMC Cancer. 11:302011. View Article : Google Scholar : PubMed/NCBI
62	Naumov VA, Generozov EV, Zaharjevskaya NB, et al: Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips. Epigenetics. 8:921–934. 2013. View Article : Google Scholar : PubMed/NCBI
63	Wang N, Du X, Zang L, et al: Prognostic impact of Metadherin-SND1 interaction in colon cancer. Mol Biol Rep. 39:10497–10504. 2012. View Article : Google Scholar : PubMed/NCBI
64	Ostrom QT, Gittleman H, Farah P, et al: CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006–2010. Neuro Oncol. 15:1–56. 2013. View Article : Google Scholar
65	Wen PY and Kesari S: Malignant gliomas in adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
66	Lefranc F, Brotchi J and Kiss R: Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol. 23:2411–2422. 2005. View Article : Google Scholar : PubMed/NCBI
67	Stupp R, Mason WP, van den Bent MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
68	Hossain MJ, Korde R, Singh S, et al: Tudor domain proteins in protozoan parasites and characterization of Plasmodium falciparum tudor staphylococcal nuclease. Int J Parasitol. 38:513–526. 2008. View Article : Google Scholar